{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:19:48Z","timestamp":1763399988657},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41401-021-00691-8","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T07:02:28Z","timestamp":1621926148000},"page":"692-702","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells"],"prefix":"10.1038","volume":"43","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-biao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"691_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"691_CR2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383:640\u20139.","journal-title":"N Engl J Med"},{"key":"691_CR3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature."},{"key":"691_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr., Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299\u2013311.","journal-title":"Lancet."},{"key":"691_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"691_CR6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.20892\/j.issn.2095-3941.2019.0158","volume":"16","author":"G Zhou","year":"2019","unstructured":"Zhou G. Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer. Cancer Biol Med. 2019;16:700\u201313.","journal-title":"Cancer Biol Med"},{"key":"691_CR7","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1021\/jm900469e","volume":"52","author":"QD You","year":"2009","unstructured":"You QD, Li ZY, Huang CH, Yang Q, Wang XJ, Guo QL, et al. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification. J Med Chem. 2009;52:5649\u201361.","journal-title":"J Med Chem"},{"key":"691_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1126\/science.1219192","volume":"336","author":"JJ Foti","year":"2012","unstructured":"Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science. 2012;336:315\u20139.","journal-title":"Science."},{"key":"691_CR9","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-2-9","volume":"2","author":"E Dopp","year":"2005","unstructured":"Dopp E, Yadav S, Ansari FA, Bhattacharya K, Von Recklinghausen U, Rauen U, et al. ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro. Part Fibre Toxicol. 2005;2:9.","journal-title":"Part Fibre Toxicol"},{"key":"691_CR10","first-page":"5","volume":"102","author":"B Halliwell","year":"1994","unstructured":"Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect. 1994;102:5\u201312.","journal-title":"Environ Health Perspect"},{"key":"691_CR11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9:338\u201350.","journal-title":"Nat Rev Cancer"},{"key":"691_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","volume":"86","author":"C Herold","year":"2002","unstructured":"Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer. 2002;86:443\u20138.","journal-title":"Br J Cancer"},{"key":"691_CR13","doi-asserted-by":"crossref","first-page":"e42960","DOI":"10.1371\/journal.pone.0042960","volume":"7","author":"K Seo","year":"2012","unstructured":"Seo K, Holt R, Jung YS, Rodriguez CO Jr., Chen X, Rebhun RB. Fluoroquinolone-mediated inhibition of cell growth, S-G2\/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines. PLoS One. 2012;7:e42960.","journal-title":"PLoS One"},{"key":"691_CR14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10096-007-0375-4","volume":"26","author":"M Paul","year":"2007","unstructured":"Paul M, Gafter-Gvili A, Fraser A, Leibovici L. The anti-cancer effects of quinolone antibiotics? Eur J Clin Microbiol Infect Dis. 2007;26:825\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"691_CR15","doi-asserted-by":"crossref","first-page":"111584","DOI":"10.1016\/j.ejmech.2019.111584","volume":"181","author":"MS Lin","year":"2019","unstructured":"Lin MS, Hong TM, Chou TH, Yang SC, Chung WC, Weng CW, et al. 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of beta-tubulin. Eur J Med Chem. 2019;181:111584.","journal-title":"Eur J Med Chem"},{"key":"691_CR16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","volume":"111","author":"V Yadav","year":"2019","unstructured":"Yadav V, Talwar P. Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: an underestimated truth. Biomed Pharmacother. 2019;111:934\u201346.","journal-title":"Biomed Pharmacother"},{"key":"691_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2018.01.008","volume":"181","author":"A Bykowska","year":"2018","unstructured":"Bykowska A, Komarnicka UK, Jezowska-Bojczuk M, Kyziol A. Cu(I) and Cu(II) complexes with phosphine derivatives of fluoroquinolone antibiotics - a comparative study on the cytotoxic mode of action. J Inorg Biochem. 2018;181:1\u201310.","journal-title":"J Inorg Biochem"},{"key":"691_CR18","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","volume":"62","author":"Y Yang","year":"2019","unstructured":"Yang Y, Cao L, Gao H, Wu Y, Wang Y, Fang F, et al. Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors. J Med Chem. 2019;62:4056\u201373.","journal-title":"J Med Chem"},{"key":"691_CR19","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1021\/acs.jmedchem.8b00124","volume":"61","author":"K Zhang","year":"2018","unstructured":"Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:quinone oxidoreductase 1 (NQO1) as a therapeutic and diagnostic target in cancer. J Med Chem. 2018;61:6983\u20137003.","journal-title":"J Med Chem"},{"key":"691_CR20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"691_CR21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/carcin\/bgt395","volume":"35","author":"Z Liu","year":"2014","unstructured":"Liu Z, Ma L, Wen ZS, Hu Z, Wu FQ, Li W, et al. Cancerous inhibitor of PP2A (CIP2A) is targeted by natural compound celastrol for degradation in non-small-cell lung cancer. Carcinogenesis. 2014;35:905\u201314.","journal-title":"Carcinogenesis."},{"key":"691_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbt.2019.08.003","volume":"54","author":"AC Reis","year":"2020","unstructured":"Reis AC, Kolvenbach BA, Nunes OC, Corvini PFX. Biodegradation of antibiotics: the new resistance determinants - part II. N Biotechnol. 2020;54:13\u201327.","journal-title":"N Biotechnol"},{"key":"691_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd4236","volume":"13","author":"KH Khoo","year":"2014","unstructured":"Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov. 2014;13:217\u201336.","journal-title":"Nat Rev Drug Discov"},{"key":"691_CR24","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1021\/acs.analchem.9b04551","volume":"92","author":"G Dong","year":"2020","unstructured":"Dong G, He S, Qin X, Liu T, Jiang Y, Li X, et al. Discovery of nonpeptide, environmentally sensitive fluorescent probes for imaging p53-MDM2 interactions in living cell lines and tissue slice. Anal Chem. 2020;92:2642\u20138.","journal-title":"Anal Chem"},{"key":"691_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2017.10.047","volume":"414","author":"L Jing","year":"2018","unstructured":"Jing L, Song F, Liu Z, Li J, Wu B, Fu Z, et al. MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Lett. 2018;414:136\u201346.","journal-title":"Cancer Lett"},{"key":"691_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","volume":"20","author":"A Hafner","year":"2019","unstructured":"Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol. 2019;20:199\u2013210.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"691_CR27","doi-asserted-by":"crossref","unstructured":"Eskandari M, Shi Y, Liu J, Albanese J, Goel S, Verma A, et al. The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2\/MDM4 dual inhibitor. Leuk Lymphoma. 2021;62:167\u201375.","DOI":"10.1080\/10428194.2020.1817441"},{"key":"691_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2020.11.013","volume":"39","author":"S Chen","year":"2021","unstructured":"Chen S, Wu JL, Liang Y, Tang YG, Song HX, Wu LL, et al. Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site. Cancer Cell. 2021;39:225\u201339.e8.","journal-title":"Cancer Cell"},{"key":"691_CR29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","volume":"19","author":"G Asher","year":"2005","unstructured":"Asher G, Tsvetkov P, Kahana C, Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 2005;19:316\u201321.","journal-title":"Genes Dev"},{"key":"691_CR30","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.biocel.2010.06.001","volume":"42","author":"KH Al-Gubory","year":"2010","unstructured":"Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010;42:1634\u201350.","journal-title":"Int J Biochem Cell Biol"},{"key":"691_CR31","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858\u201368.","journal-title":"J Biol Chem"},{"key":"691_CR32","doi-asserted-by":"crossref","first-page":"12828","DOI":"10.1073\/pnas.0910885107","volume":"107","author":"AA Khutornenko","year":"2010","unstructured":"Khutornenko AA, Roudko VV, Chernyak BV, Vartapetian AB, Chumakov PM, Evstafieva AG. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci USA. 2010;107:12828\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"691_CR33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006;11:694\u2013703.","journal-title":"Oncologist."},{"key":"691_CR34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","volume":"13","author":"MF Lavin","year":"2006","unstructured":"Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 2006;13:941\u201350.","journal-title":"Cell Death Differ"},{"key":"691_CR35","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.97.23.12513","volume":"97","author":"EC Goodwin","year":"2000","unstructured":"Goodwin EC, Dimaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA. 2000;97:12513\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"691_CR36","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1039\/b713044a","volume":"5","author":"JJ Newsome","year":"2007","unstructured":"Newsome JJ, Colucci MA, Hassani M, Beall HD, Moody CJ. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1. Org Biomol Chem. 2007;5:3665\u201373.","journal-title":"Org Biomol Chem"},{"key":"691_CR37","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1021\/acs.jmedchem.8b01424","volume":"61","author":"X Wu","year":"2018","unstructured":"Wu X, Li X, Li Z, Yu Y, You Q, Zhang X. Discovery of nonquinone substrates for NAD(P)H: quinone oxidoreductase 1 (NQO1) as effective intracellular ROS generators for the treatment of drug-resistant non-small-cell lung cancer. J Med Chem. 2018;61:11280\u201397.","journal-title":"J Med Chem"},{"key":"691_CR38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2013.357","volume":"109","author":"B Lajin","year":"2013","unstructured":"Lajin B, Alachkar A. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer. 2013;109:1325\u201337.","journal-title":"Br J Cancer"},{"key":"691_CR39","doi-asserted-by":"crossref","unstructured":"Pey AL, Megarity CF, Timson DJ. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Biosci Rep. 2019;39:BSR20180459.","DOI":"10.1042\/BSR20180459"},{"key":"691_CR40","volume":"14","author":"Y Ma","year":"2014","unstructured":"Ma Y, Kong J, Yan G, Ren X, Jin D, Jin T, et al. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:414.","journal-title":"BMC Cancer"},{"key":"691_CR41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-33-14","volume":"33","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, et al. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014;33:14.","journal-title":"J Exp Clin Cancer Res"},{"key":"691_CR42","first-page":"4752","volume":"52","author":"AM Malkinson","year":"1992","unstructured":"Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res. 1992;52:4752\u20137.","journal-title":"Cancer Res"},{"key":"691_CR43","doi-asserted-by":"crossref","first-page":"e25976","DOI":"10.1371\/journal.pone.0025976","volume":"6","author":"MT Park","year":"2011","unstructured":"Park MT, Song MJ, Lee H, Oh ET, Choi BH, Jeong SY, et al. beta-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells. PLoS One. 2011;6:e25976.","journal-title":"PLoS One"},{"key":"691_CR44","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.redox.2019.101320","volume":"28","author":"CC Patino-Morales","year":"2020","unstructured":"Patino-Morales CC, Soto-Reyes E, Arechaga-Ocampo E, Ortiz-Sanchez E, Antonio-Vejar V, Pedraza-Chaverri J, et al. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines. Redox Biol. 2020;28:101320.","journal-title":"Redox Biol"},{"key":"691_CR45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2014.08.015","volume":"438","author":"CC Chao","year":"2015","unstructured":"Chao CC. Mechanisms of p53 degradation. Clin Chim Acta. 2015;438:139\u201347.","journal-title":"Clin Chim Acta"},{"key":"691_CR46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997;387:299\u2013303.","journal-title":"Nature."},{"key":"691_CR47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296\u20139.","journal-title":"Nature."},{"key":"691_CR48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(03)00193-4","volume":"112","author":"RP Leng","year":"2003","unstructured":"Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112:779\u201391.","journal-title":"Cell."},{"key":"691_CR49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature02514","volume":"429","author":"D Dornan","year":"2004","unstructured":"Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004;429:86\u201392.","journal-title":"Nature."},{"key":"691_CR50","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1073\/pnas.202480499","volume":"99","author":"G Asher","year":"2002","unstructured":"Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA. 2002;99:13125\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"691_CR51","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1038\/sj.onc.1210188","volume":"26","author":"S Camus","year":"2007","unstructured":"Camus S, Menendez S, Cheok CF, Stevenson LF, Lain S, Lane DP. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene. 2007;26:4059\u201370.","journal-title":"Oncogene."},{"key":"691_CR52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molcel.2012.05.049","volume":"47","author":"O Moscovitz","year":"2012","unstructured":"Moscovitz O, Tsvetkov P, Hazan N, Michaelevski I, Keisar H, Ben-Nissan G, et al. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell. 2012;47:76\u201386.","journal-title":"Mol Cell"},{"key":"691_CR53","doi-asserted-by":"crossref","first-page":"26234","DOI":"10.1074\/jbc.M109.040493","volume":"284","author":"P Tsvetkov","year":"2009","unstructured":"Tsvetkov P, Reuven N, Prives C, Shaul Y. Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. J Biol Chem. 2009;284:26234\u201342.","journal-title":"J Biol Chem"},{"key":"691_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.03.019","volume":"501","author":"AT Dinkova-Kostova","year":"2010","unstructured":"Dinkova-Kostova AT, Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501:116\u201323.","journal-title":"Arch Biochem Biophys"},{"key":"691_CR55","doi-asserted-by":"crossref","first-page":"15065","DOI":"10.1073\/pnas.2436329100","volume":"100","author":"G Asher","year":"2003","unstructured":"Asher G, Lotem J, Tsvetkov P, Reiss V, Sachs L, Shaul Y. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci USA. 2003;100:15065\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"691_CR56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.5483\/BMBRep.2015.48.11.190","volume":"48","author":"ET Oh","year":"2015","unstructured":"Oh ET, Park HJ. Implications of NQO1 in cancer therapy. BMB Rep. 2015;48:609\u201317.","journal-title":"BMB Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00691-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:14:14Z","timestamp":1646136854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00691-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00691-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}